BRPI0412707B8 - processo para preparo de partículas contendo itraconazol na forma de um co-precipitado e partículas - Google Patents

processo para preparo de partículas contendo itraconazol na forma de um co-precipitado e partículas

Info

Publication number
BRPI0412707B8
BRPI0412707B8 BRPI0412707A BRPI0412707A BRPI0412707B8 BR PI0412707 B8 BRPI0412707 B8 BR PI0412707B8 BR PI0412707 A BRPI0412707 A BR PI0412707A BR PI0412707 A BRPI0412707 A BR PI0412707A BR PI0412707 B8 BRPI0412707 B8 BR PI0412707B8
Authority
BR
Brazil
Prior art keywords
particles
precipitate
preparing
containing itraconazole
particles containing
Prior art date
Application number
BRPI0412707A
Other languages
English (en)
Inventor
Lamoureux Gaël
Cousin Gérard
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of BRPI0412707A publication Critical patent/BRPI0412707A/pt
Publication of BRPI0412707B1 publication Critical patent/BRPI0412707B1/pt
Publication of BRPI0412707B8 publication Critical patent/BRPI0412707B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

partículas contendo um agente ativo na forma de um co-precipitado. a invenção refere-se a partículas contendo um agente ativo na forma de um co-precipitado, a um método de produção das referidas partículas e a formas farmacêuticas contendo as referidas partículas.
BRPI0412707A 2003-07-17 2004-07-16 processo para preparo de partículas contendo itraconazol na forma de um co-precipitado e partículas BRPI0412707B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308720A FR2857591B1 (fr) 2003-07-17 2003-07-17 Particules comprenant un principe actif sous forme de co-precipite
PCT/FR2004/001878 WO2005009411A2 (fr) 2003-07-17 2004-07-16 Particules comprenant un principe actif sous forme de co-precipite

Publications (3)

Publication Number Publication Date
BRPI0412707A BRPI0412707A (pt) 2006-09-26
BRPI0412707B1 BRPI0412707B1 (pt) 2018-11-27
BRPI0412707B8 true BRPI0412707B8 (pt) 2021-05-25

Family

ID=33548203

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412707A BRPI0412707B8 (pt) 2003-07-17 2004-07-16 processo para preparo de partículas contendo itraconazol na forma de um co-precipitado e partículas

Country Status (10)

Country Link
US (2) US20060222715A1 (pt)
EP (1) EP1651188B1 (pt)
JP (1) JP4754485B2 (pt)
CN (1) CN1822818B (pt)
BR (1) BRPI0412707B8 (pt)
CA (1) CA2532626C (pt)
ES (1) ES2544626T3 (pt)
FR (1) FR2857591B1 (pt)
MX (1) MXPA06000614A (pt)
WO (1) WO2005009411A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124895D1 (de) * 2001-07-26 2007-01-11 Ethypharm Sa Umgehüllte Allylamine oder Benzylamine enthaltende Granulate, Verfahren zur Herstellung und in der Mundhöhle dispergierbare Tabletten enthaltend die umgehüllten Granulate
CN103717289A (zh) 2011-04-11 2014-04-09 Ada-Es股份有限公司 用于气体组分捕集的流化床方法和系统
US9278314B2 (en) 2012-04-11 2016-03-08 ADA-ES, Inc. Method and system to reclaim functional sites on a sorbent contaminated by heat stable salts
BR112019009558B1 (pt) * 2017-04-13 2023-01-31 The Procter & Gamble Company Método para preparação de uma composição de produto compreendendo uma partícula distinta e uma composição-base aquosa
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
JPS62221626A (ja) * 1986-03-20 1987-09-29 Tokyo Tanabe Co Ltd １，４−ジヒドロピリジン化合物の製剤用組成物
DE69322764T2 (de) * 1992-10-09 1999-05-06 Kanegafuchi Chemical Ind Herstellungsmethode für feines granulat
JP3640980B2 (ja) * 1993-04-09 2005-04-20 株式会社林原生物化学研究所 ネコの呼吸器疾患治療剤とその治療剤を用いる治療方法
DK0904060T3 (da) * 1996-05-20 2004-04-13 Janssen Pharmaceutica Nv Antifungale præparater med forbedret biotilgængelighed
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6027747A (en) * 1997-11-11 2000-02-22 Terracol; Didier Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
FR2803748A1 (fr) * 2000-01-14 2001-07-20 Ethypharm Lab Prod Ethiques Composition d'itraconazole et procede de preparation
UY26615A1 (es) * 2000-03-16 2001-10-25 Pfizer Prod Inc Inhibidor de la glucogeno fosforilasa.
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation

Also Published As

Publication number Publication date
EP1651188B1 (fr) 2015-05-06
WO2005009411A3 (fr) 2005-03-24
WO2005009411B1 (fr) 2005-05-26
JP2007528865A (ja) 2007-10-18
US20060222715A1 (en) 2006-10-05
FR2857591B1 (fr) 2007-11-02
CN1822818B (zh) 2012-07-25
EP1651188A2 (fr) 2006-05-03
US20100266702A1 (en) 2010-10-21
CN1822818A (zh) 2006-08-23
CA2532626C (fr) 2013-03-26
FR2857591A1 (fr) 2005-01-21
ES2544626T3 (es) 2015-09-02
WO2005009411A2 (fr) 2005-02-03
CA2532626A1 (fr) 2005-02-03
BRPI0412707B1 (pt) 2018-11-27
BRPI0412707A (pt) 2006-09-26
MXPA06000614A (es) 2006-04-11
JP4754485B2 (ja) 2011-08-24

Similar Documents

Publication Publication Date Title
ITMI20032050A1 (it) Processo per la preparazione di dispersori di fluoropolimeri.
BRPI0510864A (pt) composição de microemulsão aquosa e processo para preparar uma composição de microemulsão aquosa
ATE512115T1 (de) Monodisperse nanokristalle mit kern/schale und anderen komplexen strukturen sowie herstellungsverfahren dafür
BR0116822B1 (pt) implante de osso, em particular implante intervertebral, bem como processo para sua produÇço.
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
EP1702607A4 (en) MONOPHASIC MICROEMULSION COMPOSITION, ULTRAFINE OIL-IN-WATER EMULSION AS TOPICAL FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
IL160440A0 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
CL2008001813A1 (es) Compuestos derivados de quinolin-3-carbonitrilo sustituidos con piperazina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis, inflamacion, cancer entre otras (div. sol. 266-04).
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
BRPI0506610A (pt) montelucaste sódico amorfo, processo de preparação de montelucaste sódico amorfo, composição farmacêutica, método de tratamento utilizando a administração de montelucaste sódico amorfo, co-precipitado amorfo de montelucaste sódico e processo de preparação de co-precipitado amorfo de montelucaste sódico
HK1124321A1 (en) Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them
DE60334909D1 (de) Poröse perlen und herstellungsverfahren dafür
BRPI0408922B1 (pt) processo para o tratamento termomecánico de aço.
RS50832B (sr) Agens oleogela sa sadržajem triterpena, oleogel sa sadržajem triterpena i postupak za proizvodnju oleogela sa sadržajem triterpena
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
ATE465990T1 (de) Arylalkylcarbamatderivate, verfahren zur ihrer herstellung und deren therapeutischen anwendungen
BR9807936A (pt) Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
ITRM20020529A0 (it) Polimeri sterilizzanti, processo di loro preparazione ed uso.
BRPI0412707B8 (pt) processo para preparo de partículas contendo itraconazol na forma de um co-precipitado e partículas
BR0205062B1 (pt) spandex e processo para produzir spandex.
GT200400134A (es) Sistemas emulsionantes que contienen derivados de azetidina
IL173918A0 (en) Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
GB0525944D0 (en) Water-soluble isoflavone composition, process for producing the same, and use thereof
AR036886A1 (es) Proceso para preparar un elemento en forma de gel y dispositivo para purificar el aire.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/11/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/07/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2731 DE 09-05-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.